8 Followers HKEX:1061 - Essex Bio-Technology Ltd Essex Bio-Technology Ltd
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
Add Alert 

Yahoo Finance

HKD 5.88    -0.170 (-2.81%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

16 Sep 2021



CEO: Dr. Mia Je Ngiam B.Sc.

IPO: 2001-06-27

Headquarters: HK

Employees: 1,308



Essex Bio-Technology Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in developing, manufacturing, and selling of biopharmaceutical products. The biopharmaceutical products are developed for the treatment and healing of surface wounds and eye wounds. The company reports in two segments that are Ophthalmic products and Surgical products. It focuses on the Ophthalmology and surgical arena of topical (skin) surface wounds primarily covering dermatology, stomatology, obstetrics, and gynecology. The company's products include Beifushu Eye Drops, Beifushu Gel, Beifuji Spray, Lodized Lecithin Capsule, Medictop, and others. All of the company revenues are generated from the People's republic of china.